Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Research Corporation Technologies
AddedFeb 15, 2024
UpdatedJun 28, 2026
Research Corporation Technologies

Research Corporation Technologies

Operating

RCT: A global venture capital firm investing in biotechnology, therapeutics, and medical devices.

Location
Tucson, AZ, US
Founded
1987
Firm
Compare
Portfolio
Employees
Website

Research Corporation Technologies (RCT) is a venture capital firm focused on investing in biotechnology therapeutics, tools, and medical devices globally. The firm partners with entrepreneurs, founders, innovators, and inventors to drive success in the life sciences sector. RCT specializes in translating next-generation life science inventions from concepts to patents and commercial products.

Notable portfolio companies include AustinPx, Bioinformatics, Cantex Pharmaceuticals, and Halo Labs. RCT's investment strategy spans various stages, with a concentration on Series A, B, and C rounds. The firm adds value by licensing breakthrough technologies and fostering partnerships to advance medical innovation. RCT also collaborates with AdvaMed to host the MedTech Innovator competition, supporting emerging medtech companies.

Research Corporation Technologies - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments23
Current Portfolio Count14
Total Portfolio Exits1

Top Investment Stages

Series A8 (34.8%)
Series C6 (26.1%)
Series B5 (21.7%)
Series Unknown3 (13.0%)
Series D1 (4.3%)

Stage Mix

Series A 35%Series C 26%Series B 22%Series Unknown 13%Series D 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

S2 Genomics logo

S2 Genomics

iotaMotion logo

iotaMotion

Halo Labs logo

Halo Labs

seqWell logo

seqWell

Q'Apel Medical logo

Q'Apel Medical

Bioinformatics logo

Bioinformatics

AustinPx logo

AustinPx

Orthalign logo

Orthalign

Cymedica Orthopedics logo

Cymedica Orthopedics

Providence Medical Technology logo

Providence Medical Technology

ClearFlow logo

ClearFlow

Esperance Pharmaceuticals logo

Esperance Pharmaceuticals

Cylene Pharmaceuticals logo

Cylene Pharmaceuticals

Cantex Pharmaceuticals logo

Cantex Pharmaceuticals

NP Photonics logo

NP Photonics

Similar Investment Firms

Research Triangle Ventures logo

Research Triangle Ventures

RTK Group logo

RTK Group

rtkgrp.com

RTW Venture Fund logo

RTW Venture Fund

RTX Ventures logo

RTX Ventures

rtx.com

RC Capital logo

RC Capital

rccf.com

R Ventures logo

R Ventures

rventures.co

Transhuman Capital logo

Transhuman Capital

Targeted Technology Fund logo

Targeted Technology Fund

targetedtech.com

Bioventures Investors logo

Bioventures Investors

EcoR1 Capital logo

EcoR1 Capital

ecor1cap.com

BCM Technologies logo

BCM Technologies

R7 Partners Management logo

R7 Partners Management

Emerging Technology Partners logo

Emerging Technology Partners

MedVenture Associates logo

MedVenture Associates

Republic Capital logo

Republic Capital

republiccapital.co

Research Corporation Technologies - Classification

Also Known As
  • Research Corporation Technologies, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end